Skip to main content

Table 2 Overview of ethics approvals

From: Improving quality of life in patients with rare autoimmune liver diseases by structured peer-delivered support (Q.RARE.LI): study protocol for a transnational effectiveness-implementation hybrid trial

Partner

Name of ethics committee

ID

Status

Germany, coordinating center

Independent Ethics Committee of the Hamburg Medical Chamber, Weidestr. 122 b, 22,083 Hamburg, Germany

Phone: + 49 40 202,299–240, E-mail: ethik@aekhh.de

2021–100,757-BO-ff

Approved January 31st, 2022

Canada

University Health Network Research Ethics Board, 700 University Ave, 4th Floor, Toronto, Ontario, M5G 1Z5

Phone: (416) 581–7849

22–5056

Approved February 14th, 2023

Belgium

Committee on Medical Ethics, UZ Gent, Corneel Heymanslaan 10, 9000 Ghent, Belgium

Phone: + 32 9 3,322,111, E-mail: ethisch.comite@uzgent.be

BC-10401

Approved February 22nd, 2023

Poland

The Local Ethics Committee of Medical University of Warsaw, ul. Pawińskiego 3C, 02–106 Warszawa, Poland,

Phone: + 48 22 57 20 303, E-mail: komisja.bioetyczna@wum.edu.pl

KB/26/ 2022

Approved February 21st, 2022

Hungary

Medical Research Council, Scientific and Research Ethics Committee (ETT TUKEB), 25 Alkotmány u., Budapest, H-1054, Hungary, Phone: (+ 36 1) 795 1192, E-mail: attilane.gombos@bm.gov.hu

40,513–5/2021/EÜIG,

Approved August 16th, 2021